NCT06452108

Brief Summary

In times whereby COVID-19 is rapidly spreading, research on the epidemiological, diagnostic, clinical and social aspects of the illness has been highlighted as important as there is very limited information of this disease in all these aspects. Keeping this in view, WHO has published a roadmap for global research referred to as the 2019 novel Coronavirus Global research and innovation forum: towards a research roadmap13. This document has identified around 34 knowledge gaps which need to be addressed in order to learn more about this illness. One of these gaps indicates that disease transmission is driven by both social and biological factors. Social sciences research, thus, can play a very important role in combating this illness. It can bring rich insights into social, behavioral and contextual aspects of communities, societies and populations affected by COVID-19 to enhance acceptability of and adherence to evidence-based public health measures for successful infection prevention and control (IPC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,651

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

1.1 years

First QC Date

June 7, 2024

Last Update Submit

June 12, 2024

Conditions

Keywords

community perceptionPakistanCOVID-19 preventionCOVID-19 control

Outcome Measures

Primary Outcomes (2)

  • Percentage of respondents who correctly answer questions related to COVID-19 transmission, prevention, symptoms and treatment

    This will measure knowledge regarding COVID-19 transmission, prevention, symptoms and treatment

    12 months

  • Percentage of respondents who adhered to recommended COVID-19 preventive measures

    This will measure practices such as mask-wearing, hand hygiene, social distancing, and vaccination uptake

    12 months

Study Arms (5)

Islamabad (Federal) site

Determine community perspective on COVID-19 for identification of relevant, feasible, and effective approaches to promote acceptance, uptake, and adherence of public health measures for COVID-19 prevention and control in Pakistan through generation of high-quality evidence to achieving the goals of the NAP.

Punjab site

Determine community perspective on COVID-19 for identification of relevant, feasible, and effective approaches to promote acceptance, uptake, and adherence of public health measures for COVID-19 prevention and control in Pakistan through generation of high-quality evidence to achieving the goals of the NAP.

Sindh site

Determine community perspective on COVID-19 for identification of relevant, feasible, and effective approaches to promote acceptance, uptake, and adherence of public health measures for COVID-19 prevention and control in Pakistan through generation of high-quality evidence to achieving the goals of the NAP.

Baluchistan site

Determine community perspective on COVID-19 for identification of relevant, feasible, and effective approaches to promote acceptance, uptake, and adherence of public health measures for COVID-19 prevention and control in Pakistan through generation of high-quality evidence to achieving the goals of the NAP.

KPK site

Determine community perspective on COVID-19 for identification of relevant, feasible, and effective approaches to promote acceptance, uptake, and adherence of public health measures for COVID-19 prevention and control in Pakistan through generation of high-quality evidence to achieving the goals of the NAP.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Inclusion criteria will be men and women over the age of 18 years residing within the following administrative units of Pakistan: * Islamabad (federal capital) * Punjab * Sindh * Baluchistan * Khyber Pakhtun Khwah Upon first contact with the respondents, we will ask if they would like to take part in the study. For those who have agreed to take part in the study, we will read the participant information sheet and ask the respondents to give us their verbal consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MNCHRN

Islamabad, Federal, 44000, Pakistan

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Dr Tabish Hazir, MBBS, FRCPCH

    Maternal Neonatal Child Health Research Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2024

First Posted

June 11, 2024

Study Start

April 4, 2020

Primary Completion

April 30, 2021

Study Completion

December 31, 2021

Last Updated

June 13, 2024

Record last verified: 2024-06

Locations